HLB Panagene Co., Ltd. (KOSDAQ:046210)
2,405.00
+10.00 (0.42%)
At close: Apr 9, 2026
HLB Panagene Revenue
In the year 2025, HLB Panagene had annual revenue of 15.05B KRW with 14.04% growth. HLB Panagene had revenue of 4.23B in the quarter ending December 31, 2025, with 21.89% growth.
Revenue
15.05B
Revenue Growth
+14.04%
P/S Ratio
7.27
Revenue / Employee
183.53M
Employees
81
Market Cap
109.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.05B | 1.85B | 14.04% |
| Dec 31, 2024 | 13.20B | 944.89M | 7.71% |
| Dec 31, 2023 | 12.25B | -16.39B | -57.22% |
| Dec 31, 2012 | 28.64B | -12.81B | -30.91% |
| Dec 31, 2011 | 41.45B | 7.41B | 21.77% |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Cross Medical Science | 108.41B |
| Seoulin Bioscience | 77.09B |
| Dx & Vx | 29.36B |
| Cytogen | 26.05B |
| Protia | 15.12B |
| 3billion | 11.71B |
| GENINUS | 10.48B |
| Median Diagnostics | 7.86B |